FSGEX
Price
$20.81
Change
+$0.01 (+0.05%)
Updated
Jul 31 closing price
Net Assets
74.78B
TBWCX
Price
$22.64
Change
+$0.23 (+1.03%)
Updated
Jul 31 closing price
Net Assets
477.64M
Interact to see
Advertisement

FSGEX vs TBWCX

FSGEX vs TBWCX Comparison Chart in %
View a ticker or compare two or three
VS
FSGEX vs. TBWCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Hold and TBWCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.8B vs. TBWCX (478M). FSGEX pays higher dividends than TBWCX: FSGEX (2.66) vs TBWCX (0.32). FSGEX was incepted earlier than TBWCX: FSGEX (17 years) vs TBWCX (11 years). TBWCX (2.62) is less costly to investors than FSGEX (0.01). TBWCX is a more actively managed with annual turnover of: 39.30 vs. FSGEX (8.00). FSGEX has a lower initial minimum investment than TBWCX: FSGEX (0) vs TBWCX (5000). FSGEX annual gain was more profitable for investors over the last year : 28.80 vs. TBWCX (14.44). FSGEX return over 5 years is better than : 55.46 vs. TBWCX (7.14).
FSGEXTBWCXFSGEX / TBWCX
Total Expense Ratio0.011.951%
Annual Report Gross Expense Ratio0.012.620%
Fund Existence17 years11 years-
Gain YTD13.7166.541210%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets74.8B478M15,649%
Annual Yield % from dividends2.660.32838%
Returns for 1 year28.8014.44199%
Returns for 3 years63.2235.13180%
Returns for 5 years55.467.14777%
Returns for 10 years135.0577.33175%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUCX20.370.29
+1.44%
NYLI PineStone U.S. Equity Class C
MAILX24.190.17
+0.71%
BlackRock International Instl
MMMMX56.82-0.14
-0.25%
Victory Integrity Discovery Member
PDGIX89.88-0.39
-0.43%
T. Rowe Price Dividend Growth I
MGHRX63.84-1.31
-2.01%
Morgan Stanley Inst Growth IR